The Latest Cardiac and Vascular News
DALLAS, TX, UNITED STATES, July 7, 2026 /EINPresswire.com/ — Solaris Endovascular, Inc., a medical technology company developing next-generation drug-eluting covered stents for the treatment of vascular disease, today announced the appointment of Rowan Hettel as Chief Technology Officer (CTO) and David Stack as an independent member of its Board of Directors. The appointments strengthen […]
DALLAS, TX, UNITED STATES, May 5, 2026 /EINPresswire.com/ — Solaris Endovascular, Inc, a medical device company focused on next-generation endovascular therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its first-in-class Solaris DE™ drug-eluting covered stent indicated for use in hemodialysis patients for […]
